The Medical Research Future Fund (MRFF), together with concurrent Government reviews impacting the health and medical research sector – including the Review to Strengthen Independent Medical...

The Significant Investor Visa (SIV) is a visa category for people who are willing to invest at least A$5 million into complying investments in Australia and want to maintain business and...

By all available measures of impact and success, Australia’s independent medical research institutes (iMRIs) are the jewel in the crown of Australia’s health and medical research sector. Through...

In its response to the Boosting the Commercial Returns from Research discussion paper, AAMRI contends that the most important barrier to the commercial translation of research is limited access...

In its submission to the Review of the Cooperative Research Centres (CRC) Programme, AAMRI outlines the important role of the programme in: bringing together a critical mass of multi-disciplinary ...

The National Collaborative Research Infrastructure Strategy (NCRIS) e-Research Capability Status Report, commissioned by the Department of Education, will examine the appropriateness, level of...

The Federal Government has released an options paper on proposed charity reporting and regulation arrangements following the abolition of the Australian Charities and Not-for-profits Commission...

AAMRI’s submission to the Senate Inquiry into Australia’s Innovation System addresses six priority areas for a whole-of-government innovation strategy:     Fund the full costs of research    ...

AAMRI has submitted a number of concerns about proposed changes to Australian Research Council (ARC) funding rules for Discovery Program schemes and Future Fellowships. Highlights of the AAMRI...